London: Scientists have claimed that a "molecular scalpel" has shown promising results in patients suffering from Duchenne muscular dystrophy, a deadly muscle wasting condition. The gene for the protein dystrophin is damaged in people with Duchenne muscular dystrophy. Now, a drug trial on 19 children, published in `The Lancet` journal, used the new "scalpel" to remove damage and restore dystrophin production. Duchenne muscular dystrophy affects one in every 3,500 newborn boys. Throughout life the muscle wastes away and children can need a wheelchair by the age of 10. The condition can become life-threatening before age of 30, when it affects the muscles needed to breathe and pump blood around the body.
Tejas closer to induction into IAF
No plans to drop charges against Khobragade: US
`Dhoom 3` audience verdict
Lieutenant Governor Najeeb Jung recommends President`s rule in Delhi